| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chitinase activity | 6.14e-05 | 6 | 41 | 2 | GO:0004568 | |
| GeneOntologyMolecularFunction | chitin binding | 1.14e-04 | 8 | 41 | 2 | GO:0008061 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.62e-04 | 441 | 41 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | manganese ion binding | 4.17e-04 | 71 | 41 | 3 | GO:0030145 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 9.17e-04 | 775 | 41 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.23e-03 | 103 | 41 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.45e-03 | 109 | 41 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.45e-03 | 839 | 41 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.46e-03 | 840 | 41 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.46e-03 | 840 | 41 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.48e-03 | 614 | 41 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | insulin receptor binding | 1.73e-03 | 30 | 41 | 2 | GO:0005158 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 2.35e-03 | 129 | 41 | 3 | GO:0035591 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 3.20e-03 | 144 | 41 | 3 | GO:0016798 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 5.79e-03 | 178 | 41 | 3 | GO:0015399 | |
| GeneOntologyBiologicalProcess | amino sugar catabolic process | 3.77e-06 | 15 | 43 | 3 | GO:0046348 | |
| GeneOntologyBiologicalProcess | chitin catabolic process | 6.33e-05 | 6 | 43 | 2 | GO:0006032 | |
| GeneOntologyBiologicalProcess | chitin metabolic process | 6.33e-05 | 6 | 43 | 2 | GO:0006030 | |
| GeneOntologyCellularComponent | apical part of cell | 1.87e-04 | 592 | 43 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | apical plasma membrane | 4.55e-04 | 487 | 43 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment membrane | 6.19e-04 | 81 | 43 | 3 | GO:0033116 | |
| Domain | Fibrinogen_CS | 9.99e-06 | 19 | 42 | 3 | IPR020837 | |
| Domain | Fibrinogen_a/b/g_C_2 | 2.07e-05 | 24 | 42 | 3 | IPR014715 | |
| Domain | - | 2.07e-05 | 24 | 42 | 3 | 4.10.530.10 | |
| Domain | Fibrinogen_C | 2.98e-05 | 27 | 42 | 3 | PF00147 | |
| Domain | FBG | 3.71e-05 | 29 | 42 | 3 | SM00186 | |
| Domain | - | 4.12e-05 | 30 | 42 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 4.12e-05 | 30 | 42 | 3 | IPR014716 | |
| Domain | FIBRINOGEN_C_1 | 5.01e-05 | 32 | 42 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 5.01e-05 | 32 | 42 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 5.01e-05 | 32 | 42 | 3 | PS51406 | |
| Domain | Glyco_hydro_18_chit_AS | 7.36e-05 | 6 | 42 | 2 | IPR001579 | |
| Domain | Glyco_hydro18_cat | 1.03e-04 | 7 | 42 | 2 | IPR001223 | |
| Domain | Glyco_hydro_18 | 1.03e-04 | 7 | 42 | 2 | PF00704 | |
| Domain | Chitinase_II | 1.03e-04 | 7 | 42 | 2 | IPR011583 | |
| Domain | Glyco_18 | 1.03e-04 | 7 | 42 | 2 | SM00636 | |
| Domain | CHITINASE_18 | 1.03e-04 | 7 | 42 | 2 | PS01095 | |
| Domain | Glycoside_hydrolase_SF | 2.29e-04 | 53 | 42 | 3 | IPR017853 | |
| Domain | - | 2.35e-03 | 32 | 42 | 2 | 3.40.1110.10 | |
| Domain | - | 2.35e-03 | 32 | 42 | 2 | 2.70.150.10 | |
| Domain | P-loop_NTPase | 2.61e-03 | 848 | 42 | 7 | IPR027417 | |
| Domain | ATPase_P-typ_cyto_domN | 2.80e-03 | 35 | 42 | 2 | IPR023299 | |
| Domain | - | 2.80e-03 | 35 | 42 | 2 | 3.20.20.80 | |
| Domain | P_typ_ATPase | 2.96e-03 | 36 | 42 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 2.96e-03 | 36 | 42 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 2.96e-03 | 36 | 42 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.13e-03 | 37 | 42 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.13e-03 | 37 | 42 | 2 | PF00122 | |
| Domain | Glyco_hydro_catalytic_dom | 3.30e-03 | 38 | 42 | 2 | IPR013781 | |
| Domain | AAA+_ATPase | 4.14e-03 | 144 | 42 | 3 | IPR003593 | |
| Domain | AAA | 4.14e-03 | 144 | 42 | 3 | SM00382 | |
| Domain | - | 6.12e-03 | 746 | 42 | 6 | 3.40.50.300 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 28841898 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23111423 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 18596060 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 7.81e-06 | 1070 | 45 | 9 | 23533145 | |
| Pubmed | S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity. | 9.81e-06 | 4 | 45 | 2 | 34599882 | |
| Pubmed | 1.06e-05 | 105 | 45 | 4 | 24667918 | ||
| Pubmed | 2.41e-05 | 43 | 45 | 3 | 30733279 | ||
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 22350948 | ||
| Pubmed | A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. | 7.32e-05 | 10 | 45 | 2 | 32726802 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | OSBPL11 RNF213 MGAT1 STING1 ALDH2 ANGPTL2 DNAJC10 SOD2 IQGAP1 | 8.51e-05 | 1451 | 45 | 9 | 30550785 |
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 18258609 | ||
| Pubmed | 1.94e-04 | 16 | 45 | 2 | 21572416 | ||
| Pubmed | Genetic association studies of methamphetamine use disorders: A systematic review and synthesis. | 2.47e-04 | 18 | 45 | 2 | 19219857 | |
| Pubmed | 2.54e-04 | 985 | 45 | 7 | 12975309 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 3.06e-04 | 1016 | 45 | 7 | 19056867 | |
| Pubmed | 3.06e-04 | 20 | 45 | 2 | 20437850 | ||
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 3.13e-04 | 460 | 45 | 5 | 20562862 | |
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 3.38e-04 | 21 | 45 | 2 | 25249183 | |
| Pubmed | 3.52e-04 | 259 | 45 | 4 | 31162944 | ||
| Pubmed | Chromosomal localization of the genes for five zinc finger proteins expressed in mouse lens. | 3.72e-04 | 22 | 45 | 2 | 7590745 | |
| Pubmed | 4.07e-04 | 23 | 45 | 2 | 28190640 | ||
| Pubmed | Genome-wide association with select biomarker traits in the Framingham Heart Study. | 4.07e-04 | 23 | 45 | 2 | 17903293 | |
| Pubmed | 4.70e-04 | 503 | 45 | 5 | 16964243 | ||
| Pubmed | 4.75e-04 | 504 | 45 | 5 | 34432599 | ||
| Pubmed | 4.82e-04 | 25 | 45 | 2 | 16006997 | ||
| Pubmed | 5.91e-04 | 529 | 45 | 5 | 14621295 | ||
| Pubmed | 6.17e-04 | 128 | 45 | 3 | 30995482 | ||
| Pubmed | 6.50e-04 | 29 | 45 | 2 | 15071553 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 8.43e-04 | 33 | 45 | 2 | 22357600 | |
| Pubmed | 8.68e-04 | 144 | 45 | 3 | 35681168 | ||
| GeneFamily | Fibrinogen C domain containing | 1.02e-05 | 25 | 31 | 3 | 554 | |
| GeneFamily | Chitinases | 5.94e-05 | 7 | 31 | 2 | 816 | |
| GeneFamily | Fibrinogen C domain containing|Angiopoietin like | 7.92e-05 | 8 | 31 | 2 | 905 | |
| GeneFamily | Immunoglobulin like domain containing | 4.32e-03 | 193 | 31 | 3 | 594 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.85e-05 | 156 | 45 | 4 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-05 | 156 | 45 | 4 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 157 | 45 | 4 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 158 | 45 | 4 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.26e-05 | 164 | 45 | 4 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 170 | 45 | 4 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 170 | 45 | 4 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.60e-05 | 170 | 45 | 4 | 7bba77ae34a0259fad6ee98cf665ff50f77a1328 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.60e-05 | 170 | 45 | 4 | a43b977a7fe745536cf96b7c080397d9fa73086b | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 183 | 45 | 4 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 183 | 45 | 4 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 3.54e-05 | 184 | 45 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.61e-05 | 185 | 45 | 4 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.93e-05 | 189 | 45 | 4 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 4.01e-05 | 190 | 45 | 4 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-05 | 194 | 45 | 4 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-05 | 194 | 45 | 4 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-05 | 194 | 45 | 4 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-05 | 194 | 45 | 4 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-05 | 194 | 45 | 4 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | Monocytes-cDCs|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 4.62e-05 | 197 | 45 | 4 | 15cb9fe1c3bab80bd24728fd9ac7ba385912ac33 | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.71e-05 | 198 | 45 | 4 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | Sepsis-URO-Others|URO / Disease, condition lineage and cell class | 4.71e-05 | 198 | 45 | 4 | 6caab5266da666cfbe92ac1ace26ad2004e5aa09 | |
| ToppCell | Sepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class | 4.71e-05 | 198 | 45 | 4 | d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 4.71e-05 | 198 | 45 | 4 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.89e-05 | 200 | 45 | 4 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.72e-05 | 85 | 45 | 3 | 7c5ea38893372fdecf7cc3ccf46a37b4ec45f0b1 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.72e-05 | 85 | 45 | 3 | 5a2c02aeceeabd44a417b09ac8b2e2f185070b15 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.72e-05 | 85 | 45 | 3 | 0bfabb6761a84d6a04f9fa415106a33059d78099 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 102 | 45 | 3 | 8c4d9483ff983538593f4e17f4a74a93cdda59c4 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 102 | 45 | 3 | 72ce247dad7404e6b9c971b5c29d3c6846da5efc | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 102 | 45 | 3 | 5feedce6d26a578c4aaba4e4824b3d0c3f3806bc | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 112 | 45 | 3 | 88fcd0dc12b5c00804381fb7dd59a6a2a9f37419 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 112 | 45 | 3 | fd4cc5190626cb262aae0a7f04559b0e9757270e | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 112 | 45 | 3 | d652e6fae433a6b56bf2a448fba2cf6c5e558905 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 113 | 45 | 3 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 113 | 45 | 3 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.42e-04 | 120 | 45 | 3 | e60b74758c8290919b326904ad841962256b72ec | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.42e-04 | 120 | 45 | 3 | 3e1ae5a5422729d484a90d72f779833fe3473fa8 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.42e-04 | 120 | 45 | 3 | 24d5e86931a857bb87684392172bf04294a1a46a | |
| ToppCell | -Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.47e-04 | 148 | 45 | 3 | 9952747a42e7875db92325f8edfab324951b29cc | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 4.83e-04 | 152 | 45 | 3 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.93e-04 | 153 | 45 | 3 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.93e-04 | 153 | 45 | 3 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.12e-04 | 155 | 45 | 3 | ab539c04f10276ae919d82b1c75f99a84eb695bf | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-04 | 155 | 45 | 3 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-04 | 155 | 45 | 3 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.12e-04 | 155 | 45 | 3 | 9a27558c457f05808af07190b7a5006b047f1d58 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-04 | 155 | 45 | 3 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-04 | 156 | 45 | 3 | 547e2debfc09c07c049a880dded5fda7dd53e156 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 5.21e-04 | 156 | 45 | 3 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.41e-04 | 158 | 45 | 3 | 216b3f482daa2d0d7fcaf5a8559e3ccbdb8e110d | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.41e-04 | 158 | 45 | 3 | 9712bb8b1bacb8a38c99a22bc2babec5d5160e2a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-04 | 159 | 45 | 3 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | Adult-Immune-mast_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.51e-04 | 159 | 45 | 3 | 9f53fe2e0f25448d62a591c8e528e9a49b5400d5 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.61e-04 | 160 | 45 | 3 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 165 | 45 | 3 | a6c6de17fec678ad0cac3138dde3a14cc39ffd26 | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 6.25e-04 | 166 | 45 | 3 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 6.36e-04 | 167 | 45 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.47e-04 | 168 | 45 | 3 | 5ce3129a023a48a3d7e6b9306c1fc5addfef9675 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.47e-04 | 168 | 45 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-04 | 169 | 45 | 3 | 4126b20df9e85f028807482a51e20a300faa74c2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.58e-04 | 169 | 45 | 3 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 6.58e-04 | 169 | 45 | 3 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-04 | 170 | 45 | 3 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.69e-04 | 170 | 45 | 3 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 6.69e-04 | 170 | 45 | 3 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.81e-04 | 171 | 45 | 3 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 6.81e-04 | 171 | 45 | 3 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.81e-04 | 171 | 45 | 3 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.81e-04 | 171 | 45 | 3 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.81e-04 | 171 | 45 | 3 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 6.81e-04 | 171 | 45 | 3 | 3ecd0a074344179c57eb2d9a857ba594904d00fa | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.92e-04 | 172 | 45 | 3 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 6.92e-04 | 172 | 45 | 3 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 6.92e-04 | 172 | 45 | 3 | 64928cea7e5b60e4bc4af016454b0173ebcc07c7 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.92e-04 | 172 | 45 | 3 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.92e-04 | 172 | 45 | 3 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.04e-04 | 173 | 45 | 3 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.04e-04 | 173 | 45 | 3 | 71dc0051c87b84e3cf13cde8858166f2a474b5dc | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.04e-04 | 173 | 45 | 3 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.04e-04 | 173 | 45 | 3 | 7e2149205e119cec4f5099c83c85d1e13470137a | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 7.16e-04 | 174 | 45 | 3 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-04 | 175 | 45 | 3 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-04 | 175 | 45 | 3 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 7.40e-04 | 176 | 45 | 3 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-04 | 177 | 45 | 3 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 7.52e-04 | 177 | 45 | 3 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | lung|World / shred on tissue and cell subclass | 7.65e-04 | 178 | 45 | 3 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 7.65e-04 | 178 | 45 | 3 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 178 | 45 | 3 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | ileum-Absorptive_Enterocytes|ileum / shred on tissue and cell subclass | 7.82e-04 | 41 | 45 | 2 | 650cec538c6acd92f45d804b3c94248c6231aa21 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 7.90e-04 | 180 | 45 | 3 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.90e-04 | 180 | 45 | 3 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 181 | 45 | 3 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 8.02e-04 | 181 | 45 | 3 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| Disease | Squamous cell carcinoma of esophagus | 1.03e-05 | 95 | 42 | 4 | C0279626 | |
| Disease | alcoholic liver cirrhosis (is_implicated_in) | 4.13e-05 | 7 | 42 | 2 | DOID:14018 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 4.50e-05 | 277 | 42 | 5 | C0009404 | |
| Disease | Aortic Aneurysm, Abdominal | 8.84e-05 | 10 | 42 | 2 | C0162871 | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 1.78e-04 | 14 | 42 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | Calcium channel blocker use measurement | 2.38e-04 | 213 | 42 | 4 | EFO_0009930 | |
| Disease | Vascular Diseases | 2.65e-04 | 17 | 42 | 2 | C0042373 | |
| Disease | Necrotizing Enterocolitis | 2.65e-04 | 17 | 42 | 2 | C0520459 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 2.98e-04 | 18 | 42 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | cardiomyopathy (is_implicated_in) | 3.33e-04 | 19 | 42 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 4.49e-04 | 702 | 42 | 6 | C0009402 | |
| Disease | hypertension (is_implicated_in) | 6.87e-04 | 121 | 42 | 3 | DOID:10763 (is_implicated_in) | |
| Disease | angina pectoris | 7.55e-04 | 125 | 42 | 3 | EFO_0003913 | |
| Disease | systolic blood pressure, alcohol drinking | 8.09e-04 | 128 | 42 | 3 | EFO_0004329, EFO_0006335 | |
| Disease | hypertension | 9.42e-04 | 307 | 42 | 4 | EFO_0000537 | |
| Disease | coffee consumption | 9.55e-04 | 32 | 42 | 2 | EFO_0004330 | |
| Disease | Alcoholic Intoxication | 9.55e-04 | 32 | 42 | 2 | C0001969 | |
| Disease | Brain Tumor, Primary | 1.02e-03 | 33 | 42 | 2 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 1.02e-03 | 33 | 42 | 2 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 1.02e-03 | 33 | 42 | 2 | C0750977 | |
| Disease | Neoplasms, Intracranial | 1.02e-03 | 33 | 42 | 2 | C1527390 | |
| Disease | Benign neoplasm of brain, unspecified | 1.02e-03 | 33 | 42 | 2 | C0496899 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.08e-03 | 34 | 42 | 2 | EFO_0009926 | |
| Disease | Malignant neoplasm of brain | 1.35e-03 | 38 | 42 | 2 | C0153633 | |
| Disease | Brain Neoplasms | 1.42e-03 | 39 | 42 | 2 | C0006118 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKDGEALKYWYENHN | 146 | P12319 | |
| ITYWLNRDRNGHEYY | 101 | Q9H1Z8 | |
| IPYYDNLKQAYWGHR | 631 | Q8TDI0 | |
| GWYFYVQAYKSLRHR | 711 | P35670 | |
| NYANYHDTSPYRWGG | 246 | O95490 | |
| GHYRSRYQDGVYWAE | 456 | Q9UKU9 | |
| SGQGRYRNLWEHYYK | 71 | Q9H0F7 | |
| YRNLWEHYYKEGQAI | 76 | Q9H0F7 | |
| HNESQNLYGYNWYKG | 56 | Q14002 | |
| NLYGYNWYKGERVHA | 61 | Q14002 | |
| YHHLAGYKGVWFKYE | 1261 | Q96PN6 | |
| YNYKDPAGHFHQVWY | 316 | Q01459 | |
| RRHSGKDWYLNLNYG | 321 | Q9Y2Q0 | |
| VKHWVKGGYYYYHNL | 686 | P46940 | |
| HVYQAYWKAVGQGLA | 871 | Q5T3U5 | |
| AYRGHLQRTYQYAWA | 41 | Q5HY92 | |
| GYYKIARHYRWALGQ | 181 | P26572 | |
| GHLQGYRIYYWKTQS | 876 | Q92823 | |
| LCAWYLYGEKHRGYA | 401 | O95822 | |
| ARANHYEDYGDYWRG | 191 | Q9BYF1 | |
| GHYRSRYQDGVYWAE | 436 | Q8NI99 | |
| SNKAYHYHSYNGWNR | 641 | Q8IXB1 | |
| YIGWDKHYGFQLYQS | 136 | P25789 | |
| YGDFQRHWDALYGYK | 226 | Q68DL7 | |
| KHWIDYQYVPYANKG | 311 | Q12889 | |
| GWQYSDHMENVYGYL | 51 | Q9BXB4 | |
| VYKVHGNYGRVFSEW | 251 | O95219 | |
| AHGLAWSYYIGYLRL | 156 | Q86WV6 | |
| GLHQAVNGLGWYYHK | 761 | Q68CR1 | |
| EWYIGYYQGRVGLVH | 701 | Q9P0V3 | |
| WFKQYIYVYHITGQG | 176 | P0C866 | |
| NWGKQYDVHSLYGYS | 551 | P14410 | |
| LRYYAGWADKYHGKT | 146 | P05091 | |
| QGYWAQSHALRGKVY | 41 | Q9ULP9 | |
| LLGSGDWHQYYDIVY | 486 | Q63HN8 | |
| WVGNCVGKRNYRYFY | 171 | Q9Y397 | |
| PYQHRYRLYGQWKNE | 516 | Q8NI27 | |
| GEAIGNYYINWYRKT | 46 | A0JD36 | |
| RYYEANYWQFPDGIH | 76 | Q9UKY0 | |
| YIYKQIDQNWYEGEH | 821 | Q9BX66 | |
| WYRNCHYANLNGLYG | 4191 | P22105 | |
| WLLERKLYGYQAQHY | 181 | Q99727 | |
| GIDVWEHAYYLQYKN | 181 | P04179 | |
| ANAGHYWAYIYNQPR | 596 | Q96RU2 | |
| GNEYVYWYRQIHSQG | 46 | A0A087WT03 | |
| YWVIGLQHNHEYRAY | 401 | Q9C030 | |
| GGYVHYGDWLKVRMY | 96 | Q96IK0 |